Rapid development of an inactivated vaccine for SARS-CoV-2
Q. Gao, L. Bao, H. Mao, L. Wang, K. Xu, m. Yang, Y. Li, L. Zhu, N. Wang, Z. Lv, H. Gao, X. Ge, B. Kan, Y. Hu, J. Liu, , C. Qin
A purified inactivated SARS-CoV-2 vaccine candidate (PiCoVacc) induces neutralizing antibodies in animals and shows safety and partial to complete protection against SARS-CoV-2 strains.
bioRxiv · Apr 17, 2020Microbiology